| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lexicon Pharmaceuticals, Inc. (LXRX) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 1 sell. LXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.91M | $4.00M | - | |
| CEO | 1.01M | $2.11M | - | |
| CFO | 160.2K | $336.5K | - | |
| VP | 156.0K | $327.7K | - | |
| VP | 149.3K | $313.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 23, 2016 | Tessmer James F | VP, Finance &Accounting | Sale+OE | 6,000 | $13.00 | $78,000.00 | -27.3% |